Annual Operating Profit
$8.20 B
-$909.00 M-9.98%
31 December 2023
Summary:
Bristol-Myers Squibb annual operaing income is currently $8.20 billion, with the most recent change of -$909.00 million (-9.98%) on 31 December 2023. During the last 3 years, it has risen by +$6.02 billion (+276.44%). BMY annual operating profit is now -9.98% below its all-time high of $9.10 billion, reached on 31 December 2022.BMY Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$2.17 B
+$481.00 M+28.44%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly operating income is currently $2.17 billion, with the most recent change of +$481.00 million (+28.44%) on 30 September 2024. Over the past year, it has increased by +$213.00 million (+10.87%). BMY quarterly operating profit is now -18.62% below its all-time high of $2.67 billion, reached on 31 March 2022.BMY Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$7.28 B
+$213.00 M+3.01%
30 September 2024
Summary:
Bristol-Myers Squibb TTM operating income is currently $7.28 billion, with the most recent change of +$213.00 million (+3.01%) on 30 September 2024. Over the past year, it has dropped by -$706.00 million (-8.84%). BMY TTM operating profit is now -25.33% below its all-time high of $9.75 billion, reached on 30 September 2022.BMY TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.0% | +10.9% | -8.8% |
| 3 y3 years | +276.4% | +7.6% | +35.9% |
| 5 y5 years | +60.3% | +23.5% | +5.3% |
BMY Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -10.0% | +276.4% | -18.6% | +43.5% | -25.3% | +35.9% |
| 5 y | 5 years | -10.0% | +276.4% | -18.6% | +358.9% | -25.3% | +234.4% |
| alltime | all time | -10.0% | +656.7% | -18.6% | +137.8% | -25.3% | +290.1% |
Bristol-Myers Squibb Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.17 B(+28.4%) | $7.28 B(+3.0%) |
| June 2024 | - | $1.69 B(+11.7%) | $7.07 B(-2.9%) |
| Mar 2024 | - | $1.51 B(-20.4%) | $7.28 B(-11.2%) |
| Dec 2023 | $8.20 B(-10.0%) | $1.90 B(-2.9%) | $8.20 B(+2.6%) |
| Sept 2023 | - | $1.96 B(+3.1%) | $7.99 B(-1.7%) |
| June 2023 | - | $1.90 B(-21.8%) | $8.13 B(-8.4%) |
| Mar 2023 | - | $2.43 B(+43.6%) | $8.87 B(-2.6%) |
| Dec 2022 | $9.10 B(+6.6%) | $1.69 B(-19.3%) | $9.10 B(-6.6%) |
| Sept 2022 | - | $2.10 B(-20.6%) | $9.75 B(+0.8%) |
| June 2022 | - | $2.64 B(-1.0%) | $9.67 B(+3.2%) |
| Mar 2022 | - | $2.67 B(+14.1%) | $9.37 B(+9.8%) |
| Dec 2021 | $8.54 B(+292.1%) | $2.34 B(+15.9%) | $8.54 B(+59.3%) |
| Sept 2021 | - | $2.02 B(-13.9%) | $5.36 B(+14.5%) |
| June 2021 | - | $2.34 B(+27.8%) | $4.68 B(+45.0%) |
| Mar 2021 | - | $1.83 B(-318.6%) | $3.23 B(+48.3%) |
| Dec 2020 | $2.18 B(-63.2%) | -$839.00 M(-162.5%) | $2.18 B(-39.1%) |
| Sept 2020 | - | $1.34 B(+50.6%) | $3.58 B(-10.4%) |
| June 2020 | - | $891.00 M(+13.8%) | $3.99 B(-19.8%) |
| Mar 2020 | - | $783.00 M(+39.8%) | $4.98 B(-15.8%) |
| Dec 2019 | $5.91 B(+15.6%) | $560.00 M(-68.2%) | $5.91 B(-14.5%) |
| Sept 2019 | - | $1.76 B(-6.2%) | $6.92 B(+1.5%) |
| June 2019 | - | $1.88 B(+9.2%) | $6.82 B(+25.0%) |
| Mar 2019 | - | $1.72 B(+9.9%) | $5.45 B(+6.6%) |
| Dec 2018 | $5.11 B(+48.4%) | $1.56 B(-5.8%) | $5.11 B(+25.9%) |
| Sept 2018 | - | $1.66 B(+223.4%) | $4.06 B(+21.1%) |
| June 2018 | - | $513.00 M(-62.8%) | $3.35 B(-5.5%) |
| Mar 2018 | - | $1.38 B(+170.4%) | $3.55 B(+3.0%) |
| Dec 2017 | $3.45 B(-22.9%) | $510.00 M(-46.4%) | $3.45 B(-10.2%) |
| Sept 2017 | - | $951.00 M(+34.1%) | $3.84 B(-8.7%) |
| June 2017 | - | $709.00 M(-44.4%) | $4.20 B(-9.2%) |
| Mar 2017 | - | $1.28 B(+41.5%) | $4.63 B(+3.6%) |
| Dec 2016 | $4.47 B(+158.2%) | $902.00 M(-31.5%) | $4.47 B(+30.1%) |
| Sept 2016 | - | $1.32 B(+15.8%) | $3.43 B(+25.6%) |
| June 2016 | - | $1.14 B(+2.1%) | $2.73 B(+58.9%) |
| Mar 2016 | - | $1.11 B(-949.6%) | $1.72 B(-0.5%) |
| Dec 2015 | $1.73 B(+0.9%) | -$131.00 M(-121.3%) | $1.73 B(-7.0%) |
| Sept 2015 | - | $616.00 M(+400.8%) | $1.86 B(-4.5%) |
| June 2015 | - | $123.00 M(-89.0%) | $1.95 B(-8.3%) |
| Mar 2015 | - | $1.12 B(<-9900.0%) | $2.12 B(+23.9%) |
| Dec 2014 | $1.71 B(-41.5%) | -$1.00 M(-100.1%) | $1.71 B(-33.5%) |
| Sept 2014 | - | $703.00 M(+135.1%) | $2.58 B(-3.1%) |
| June 2014 | - | $299.00 M(-58.1%) | $2.66 B(-11.0%) |
| Mar 2014 | - | $713.00 M(-17.3%) | $2.99 B(+2.0%) |
| Dec 2013 | $2.93 B(-25.5%) | $862.00 M(+9.7%) | $2.93 B(+13.0%) |
| Sept 2013 | - | $786.00 M(+25.2%) | $2.59 B(+9.7%) |
| June 2013 | - | $628.00 M(-4.1%) | $2.36 B(-13.8%) |
| Mar 2013 | - | $655.00 M(+25.0%) | $2.74 B(-30.2%) |
| Dec 2012 | $3.93 B(-40.8%) | $524.00 M(-5.9%) | $3.93 B(-21.0%) |
| Sept 2012 | - | $557.00 M(-44.7%) | $4.98 B(-19.2%) |
| June 2012 | - | $1.01 B(-45.3%) | $6.16 B(-10.6%) |
| Mar 2012 | - | $1.84 B(+17.5%) | $6.89 B(+3.8%) |
| Dec 2011 | $6.64 B(+11.5%) | $1.57 B(-9.9%) | $6.64 B(+2.8%) |
| Sept 2011 | - | $1.74 B(+0.2%) | $6.46 B(+2.7%) |
| June 2011 | - | $1.74 B(+9.2%) | $6.29 B(+3.7%) |
| Mar 2011 | - | $1.59 B(+14.6%) | $6.06 B(+1.9%) |
| Dec 2010 | $5.95 B(+9.4%) | $1.39 B(-11.6%) | $5.95 B(-3.8%) |
| Sept 2010 | - | $1.57 B(+3.9%) | $6.18 B(+2.1%) |
| June 2010 | - | $1.51 B(+2.2%) | $6.05 B(+2.2%) |
| Mar 2010 | - | $1.48 B(-8.7%) | $5.92 B(+8.9%) |
| Dec 2009 | $5.44 B(+8.3%) | $1.62 B(+12.3%) | $5.44 B(+0.4%) |
| Sept 2009 | - | $1.44 B(+4.4%) | $5.42 B(+4.4%) |
| June 2009 | - | $1.38 B(+38.7%) | $5.19 B(+1.9%) |
| Mar 2009 | - | $996.00 M(-37.7%) | $5.10 B(-1.7%) |
| Dec 2008 | $5.02 B(+42.4%) | $1.60 B(+31.5%) | $5.19 B(+10.8%) |
| Sept 2008 | - | $1.22 B(-5.4%) | $4.68 B(+7.8%) |
| June 2008 | - | $1.28 B(+18.3%) | $4.34 B(+11.1%) |
| Mar 2008 | - | $1.09 B(-0.6%) | $3.91 B(+8.3%) |
| Dec 2007 | $3.53 B(+47.9%) | $1.09 B(+24.5%) | $3.61 B(+44.6%) |
| Sept 2007 | - | $878.00 M(+3.2%) | $2.50 B(+20.2%) |
| June 2007 | - | $851.00 M(+8.4%) | $2.08 B(-7.9%) |
| Mar 2007 | - | $785.00 M(-4231.6%) | $2.25 B(-5.5%) |
| Dec 2006 | $2.39 B(-36.2%) | -$19.00 M(-104.1%) | $2.39 B(-21.2%) |
| Sept 2006 | - | $458.00 M(-55.5%) | $3.03 B(-14.7%) |
| June 2006 | - | $1.03 B(+12.3%) | $3.55 B(-2.6%) |
| Mar 2006 | - | $917.00 M(+47.4%) | $3.64 B(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2005 | $3.74 B(-16.3%) | $622.00 M(-36.5%) | $3.74 B(-9.2%) |
| Sept 2005 | - | $980.00 M(-12.8%) | $4.12 B(-4.5%) |
| June 2005 | - | $1.12 B(+11.2%) | $4.31 B(-0.5%) |
| Mar 2005 | - | $1.01 B(+1.0%) | $4.33 B(-3.0%) |
| Dec 2004 | $4.46 B(-9.5%) | $1.00 B(-14.6%) | $4.46 B(-3.4%) |
| Sept 2004 | - | $1.17 B(+2.2%) | $4.62 B(-4.6%) |
| June 2004 | - | $1.15 B(+0.3%) | $4.84 B(-2.1%) |
| Mar 2004 | - | $1.14 B(-1.1%) | $4.95 B(+0.3%) |
| Dec 2003 | $4.93 B(+20.3%) | $1.16 B(-17.1%) | $4.93 B(+10.5%) |
| Sept 2003 | - | $1.40 B(+11.4%) | $4.46 B(+7.7%) |
| June 2003 | - | $1.25 B(+10.9%) | $4.14 B(+10.7%) |
| Mar 2003 | - | $1.13 B(+64.1%) | $3.74 B(-8.7%) |
| Dec 2002 | $4.10 B(-20.5%) | $688.00 M(-36.0%) | $4.10 B(-4.6%) |
| Sept 2002 | - | $1.07 B(+26.2%) | $4.30 B(-9.2%) |
| June 2002 | - | $852.00 M(-42.7%) | $4.74 B(-11.7%) |
| Mar 2002 | - | $1.49 B(+67.7%) | $5.36 B(-2.3%) |
| Dec 2001 | $5.16 B(-13.8%) | $886.00 M(-41.4%) | $5.49 B(-11.6%) |
| Sept 2001 | - | $1.51 B(+2.4%) | $6.21 B(-0.2%) |
| June 2001 | - | $1.48 B(-8.3%) | $6.22 B(-0.4%) |
| Mar 2001 | - | $1.61 B(+0.2%) | $6.24 B(+1.3%) |
| Dec 2000 | $5.99 B(+14.3%) | $1.61 B(+5.2%) | $6.16 B(+3.7%) |
| Sept 2000 | - | $1.53 B(+1.9%) | $5.95 B(+3.2%) |
| June 2000 | - | $1.50 B(-2.0%) | $5.76 B(+3.2%) |
| Mar 2000 | - | $1.53 B(+10.2%) | $5.58 B(+1.0%) |
| Dec 1999 | $5.24 B(+17.6%) | $1.39 B(+3.5%) | $5.53 B(+15.3%) |
| Sept 1999 | - | $1.34 B(+1.8%) | $4.79 B(-0.1%) |
| June 1999 | - | $1.32 B(-10.7%) | $4.79 B(+3.3%) |
| Mar 1999 | - | $1.48 B(+125.7%) | $4.64 B(+4.1%) |
| Dec 1998 | $4.46 B(+0.4%) | $654.00 M(-51.4%) | $4.46 B(-8.7%) |
| Sept 1998 | - | $1.35 B(+15.6%) | $4.88 B(+3.2%) |
| June 1998 | - | $1.16 B(-9.9%) | $4.73 B(+2.9%) |
| Mar 1998 | - | $1.29 B(+20.0%) | $4.60 B(+3.6%) |
| Dec 1997 | $4.44 B(+12.3%) | $1.08 B(-9.9%) | $4.44 B(+3.0%) |
| Sept 1997 | - | $1.20 B(+15.9%) | $4.31 B(+3.3%) |
| June 1997 | - | $1.03 B(-8.9%) | $4.17 B(+2.7%) |
| Mar 1997 | - | $1.13 B(+19.5%) | $4.06 B(+2.8%) |
| Dec 1996 | $3.95 B(+9.3%) | $948.00 M(-10.6%) | $3.95 B(+2.2%) |
| Sept 1996 | - | $1.06 B(+14.8%) | $3.87 B(+2.7%) |
| June 1996 | - | $923.00 M(-9.7%) | $3.77 B(+1.6%) |
| Mar 1996 | - | $1.02 B(+18.4%) | $3.71 B(+2.5%) |
| Dec 1995 | $3.62 B(+12.2%) | $863.00 M(-9.9%) | $3.62 B(+3.3%) |
| Sept 1995 | - | $958.00 M(+11.1%) | $3.50 B(+2.5%) |
| June 1995 | - | $862.00 M(-7.5%) | $3.42 B(+2.7%) |
| Mar 1995 | - | $932.00 M(+24.6%) | $3.33 B(+3.2%) |
| Dec 1994 | $3.22 B(+34.0%) | $748.00 M(-14.4%) | $3.22 B(+25.3%) |
| Sept 1994 | - | $874.00 M(+13.2%) | $2.57 B(+2.0%) |
| June 1994 | - | $772.00 M(-6.8%) | $2.52 B(+2.8%) |
| Mar 1994 | - | $828.00 M(+744.9%) | $2.45 B(+2.1%) |
| Dec 1993 | $2.40 B(+22.6%) | $98.00 M(-88.1%) | $2.40 B(+18.0%) |
| Sept 1993 | - | $823.00 M(+16.9%) | $2.04 B(+0.7%) |
| June 1993 | - | $704.00 M(-9.5%) | $2.02 B(+1.8%) |
| Mar 1993 | - | $778.00 M(-390.3%) | $1.99 B(+1.4%) |
| Dec 1992 | $1.96 B(-29.1%) | -$268.00 M(-133.2%) | $1.96 B(-30.3%) |
| Sept 1992 | - | $808.00 M(+20.8%) | $2.81 B(+0.9%) |
| June 1992 | - | $669.00 M(-10.9%) | $2.79 B(-0.9%) |
| Mar 1992 | - | $751.00 M(+28.8%) | $2.81 B(+1.7%) |
| Dec 1991 | $2.77 B(+15.8%) | $583.00 M(-25.6%) | $2.77 B(+4.2%) |
| Sept 1991 | - | $784.00 M(+12.8%) | $2.65 B(+2.6%) |
| June 1991 | - | $695.00 M(-1.3%) | $2.59 B(+3.6%) |
| Mar 1991 | - | $704.00 M(+49.2%) | $2.50 B(+4.6%) |
| Dec 1990 | $2.39 B(+120.6%) | $472.00 M(-34.1%) | $2.39 B(-162.4%) |
| Sept 1990 | - | $716.00 M(+18.2%) | -$3.83 B(+72.1%) |
| June 1990 | - | $606.00 M(+1.8%) | -$2.23 B(+279.0%) |
| Mar 1990 | - | $595.00 M(-110.4%) | -$587.00 M(-154.2%) |
| Dec 1989 | $1.08 B(-38.8%) | -$5.75 B(-347.7%) | $1.08 B(-50.4%) |
| Sept 1989 | - | $2.32 B(+3.4%) | $2.19 B(+6.0%) |
| June 1989 | - | $2.24 B(-0.9%) | $2.06 B(+7.5%) |
| Mar 1989 | - | $2.27 B(-148.8%) | $1.92 B(+8.4%) |
| Dec 1988 | $1.77 B(+20.7%) | -$4.64 B(-311.5%) | $1.77 B(-20.0%) |
| Sept 1988 | - | $2.20 B(+4.5%) | $2.21 B(+16.1%) |
| June 1988 | - | $2.10 B(-0.8%) | $1.91 B(+12.5%) |
| Mar 1988 | - | $2.12 B(-150.4%) | $1.69 B(+15.5%) |
| Dec 1987 | $1.47 B | -$4.20 B(-322.4%) | $1.47 B(-74.1%) |
| Sept 1987 | - | $1.89 B(0.0%) | $5.67 B(+50.0%) |
| June 1987 | - | $1.89 B(0.0%) | $3.78 B(+100.0%) |
| Mar 1987 | - | $1.89 B | $1.89 B |
FAQ
- What is Bristol-Myers Squibb annual operaing income?
- What is the all time high annual operating profit for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual operating profit year-on-year change?
- What is Bristol-Myers Squibb quarterly operating income?
- What is the all time high quarterly operating profit for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly operating profit year-on-year change?
- What is Bristol-Myers Squibb TTM operating income?
- What is the all time high TTM operating profit for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM operating profit year-on-year change?
What is Bristol-Myers Squibb annual operaing income?
The current annual operating profit of BMY is $8.20 B
What is the all time high annual operating profit for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual operaing income is $9.10 B
What is Bristol-Myers Squibb annual operating profit year-on-year change?
Over the past year, BMY annual operaing income has changed by -$909.00 M (-9.98%)
What is Bristol-Myers Squibb quarterly operating income?
The current quarterly operating profit of BMY is $2.17 B
What is the all time high quarterly operating profit for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly operating income is $2.67 B
What is Bristol-Myers Squibb quarterly operating profit year-on-year change?
Over the past year, BMY quarterly operating income has changed by +$213.00 M (+10.87%)
What is Bristol-Myers Squibb TTM operating income?
The current TTM operating profit of BMY is $7.28 B
What is the all time high TTM operating profit for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM operating income is $9.75 B
What is Bristol-Myers Squibb TTM operating profit year-on-year change?
Over the past year, BMY TTM operating income has changed by -$706.00 M (-8.84%)